A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?-Reference-Cited by-同舟云学术

A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?

Published:1998-10 Issue:4 Volume:44 Page:629-634
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Karussis Dimitrios,Leker Ronen R.,Ashekenazi Avi,Abramsky Oded

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference60 articles.

1. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

2. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases

3. Neurological Aspects of Antiphospholipid Antibody Syndrome

4. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke

5. Anticardiolipin Antibodies and the Risk of Recurrent Thrombo-occlusive Events and Death

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus;Rheumatology;2024-02-01

2. Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis;Neurologia i Neurochirurgia Polska;2023-07-19

3. Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management;Drugs;2023-02

4. Clinical Significance of Resist β2-Glycoprotein 1 Antibody;Advances in Clinical Medicine;2023

5. The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases;Fundamental Research;2022-12